{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17"],"submitter":["Scherer TP"],"pubmed_abstract":["<h4>Background</h4>Transurethral resection of the bladder (TURB) harbors a high-risk for postoperative bleeding, especially in patients requiring anticoagulation. Recently, direct oral anticoagulants (DOACs) have become a popular alternative to vitamin K antagonists (VKAs), though their impact on TURB complications remains unclear.<h4>Objectives</h4>To assess the postoperative complications of TURB from patients taking DOACs and VKAs.<h4>Design</h4>Retrospective cohort study.<h4>Materials and methods</h4>We retrospectively identified anticoagulated patients undergoing a TURB at our institution between 2012 and 2022 and divided them into two groups: whether they received VKA or DOAC. Follow-up of each patient was performed for 3 months. Occurrence and time to event of postoperative bleeding"],"journal":["Therapeutic advances in urology"],"pagination":["17562872251315930"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11792014"],"repository":["biostudies-literature"],"pubmed_title":["Risk of postoperative bleeding and thromboembolic events in anticoagulated patients undergoing transurethral resection of bladder tumors."],"pmcid":["PMC11792014"],"pubmed_authors":["Bieri U","Scherer TP","Dam C","Strebel R","Eberli D"],"additional_accession":[]},"is_claimable":false,"name":"Risk of postoperative bleeding and thromboembolic events in anticoagulated patients undergoing transurethral resection of bladder tumors.","description":"<h4>Background</h4>Transurethral resection of the bladder (TURB) harbors a high-risk for postoperative bleeding, especially in patients requiring anticoagulation. Recently, direct oral anticoagulants (DOACs) have become a popular alternative to vitamin K antagonists (VKAs), though their impact on TURB complications remains unclear.<h4>Objectives</h4>To assess the postoperative complications of TURB from patients taking DOACs and VKAs.<h4>Design</h4>Retrospective cohort study.<h4>Materials and methods</h4>We retrospectively identified anticoagulated patients undergoing a TURB at our institution between 2012 and 2022 and divided them into two groups: whether they received VKA or DOAC. Follow-up of each patient was performed for 3 months. Occurrence and time to event of postoperative bleeding","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan-Dec","modification":"2025-04-22T12:36:33.515Z","creation":"2025-04-06T00:26:20.432Z"},"accession":"S-EPMC11792014","cross_references":{"pubmed":["39906152"],"doi":["10.1177/17562872251315930"]}}